John N Bonfiglio Net Worth

The estimated Net Worth of John N Bonfiglio is at least $15.6 millier dollars as of 12 December 2016. John Bonfiglio owns over 10,417 units of Oragenics Inc stock worth over $15,626 and over the last 12 years John sold OGEN stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

John Bonfiglio OGEN stock SEC Form 4 insiders trading

John has made over 2 trades of the Oragenics Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently John exercised 10,417 units of OGEN stock worth $18,126 on 12 December 2016.

The largest trade John's ever made was exercising 10,417 units of Oragenics Inc stock on 12 December 2016 worth over $18,126. On average, John trades about 1,427 units every 107 days since 2012. As of 12 December 2016 John still owns at least 31,251 units of Oragenics Inc stock.

You can see the complete history of John Bonfiglio stock trades at the bottom of the page.

What's John Bonfiglio's mailing address?

John's mailing address filed with the SEC is 3000 BAYPORT DRIVE, SUITE 685, TAMPA, FL, 33607.

Insiders trading at Oragenics Inc

Over the last 12 years, insiders at Oragenics Inc have traded over $5,827,684 worth of Oragenics Inc stock and bought 8,095,027 units worth $13,189,855 . The most active insiders traders include Randal Jintrexon Corp Kirk, Joseph Hernandez et Robert C Koski. On average, Oragenics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $151,398. The most recent stock trade was executed by Fred Telling on 30 November 2023, trading 3,500 units of OGEN stock currently worth $12,495.

What does Oragenics Inc do?

oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies. offerings are based on the probiora3 technology and brands include evoraplus™ is a new, one-of-a-kind probiotic mint that naturally supports gum and tooth health while freshening breath and whitening teeth. oragenics has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, in diagnostics, and in oral health.

Complete history of John Bonfiglio stock trades at Oragenics Inc

Oragenics Inc executives and stock owners

Oragenics Inc executives and other stock owners filed with the SEC include:

• Michael O. Sullivan CPA,
  CFO, Sec., Treasurer & Interim Principal Exec. Officer
• Dr. Martin Handfield M.Sc., Ph.D.,
  Sr. VP of Discovery Research
• Michael Sullivan,
  Chief Financial Officer, Treasurer, Secretary
• Dr. Frederick W. Telling Ph.D.,
  Exec. Chairman
• Charles Pope,
  Independent Director
• Robert Koski,
  Independent Director
• Alan Dunton,
  Independent Director
• Kim Murphy,
  Director
• Alan Joslyn,
  President, Chief Executive Officer, Director
• Frederick Telling,
  Independent Chairman of the Board
• Dr. Raman Bedi,
  Chairman of International Scientific Advisory Board and Sr. Consultant
• Joseph Hernandez,
  10% owner
• John P Gandolfo,
  Director
• Bruce A. Sr. Cassidy,
  Director
• Randal Jintrexon Corp Kirk,
  
• Fred Telling,
  Director
• Family Lpkoski Robert Ckosk...,
  
• Janet Huffman,
  CFO, Secretary and Treasurer
• Christine L Koski,
  
• Family Lp Koski,
  
• Thomas L Koski,
  
• Beverly Koski,
  
• Robert Ckoski Christine Lko...,
  
• Family Lpkoski Christine Lk...,
  
• John N Bonfiglio,
  President and CEO
• Family Lpkoski Beverlykoski...,
  
• J Michael Redmond,
  President
• Robert C Koski,
  Director